Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
03 Janeiro 2024 - 10:00AM
Business Wire
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in
serving science, announced that Marc N. Casper, chairman, president
and chief executive officer, will present at the 42nd Annual J.P.
Morgan Healthcare Conference on Tuesday, January 9, 2024, at 11:15
a.m. (EST).
You can access the webcast of the presentation via the Investors
section of our website, www.thermofisher.com.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue over $40 billion. Our Mission is to
enable our customers to make the world healthier, cleaner and
safer. Whether our customers are accelerating life sciences
research, solving complex analytical challenges, increasing
productivity in their laboratories, improving patient health
through diagnostics or the development and manufacture of
life-changing therapies, we are here to support them. Our global
team delivers an unrivaled combination of innovative technologies,
purchasing convenience and pharmaceutical services through our
industry-leading brands, including Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services,
Patheon and PPD. For more information, please visit
www.thermofisher.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103392406/en/
Media Contact Information: Sandy Pound Thermo Fisher Scientific
Phone: 781-622-1223 E-mail: sandy.pound@thermofisher.com
Investor Contact Information: Rafael Tejada Thermo Fisher
Scientific Phone: 781-622-1356 E-mail:
rafael.tejada@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024